Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,894 | 36,951 | 10,114 | 8,188 | 5,119 |
| Depreciation Amortization | 3,089 | 9,524 | 6,307 | 4,511 | 1,750 |
| Income taxes - deferred | -843 | -23,732 | N/A | N/A | N/A |
| Accounts receivable | -11,071 | -16,442 | -10,848 | 2,845 | -10,172 |
| Other Working Capital | 2,439 | 429 | 2,065 | 6,240 | -12,179 |
| Other Operating Activity | 11,276 | 15,469 | 11,829 | -2,168 | 11,087 |
| Operating Cash Flow | $2,996 | $22,199 | $19,467 | $19,616 | $-4,395 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,240 | -4,242 | -2,875 | -1,820 | -556 |
| Net Acquisitions | N/A | -86,467 | -3,500 | N/A | N/A |
| Purchase Of Investment | -2,464 | -87,171 | -80,998 | -52,750 | -21,784 |
| Sale Of Investment | 1,000 | 181,352 | 174,722 | 52,047 | 21,250 |
| Purchase Sale Intangibles | -100 | -4,404 | -2,863 | -1,546 | -989 |
| Other Investing Activity | -100 | -4,404 | -2,863 | -1,546 | -989 |
| Investing Cash Flow | $-3,804 | $-932 | $84,486 | $-4,069 | $-2,079 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -260 | -10,420 | -10,324 | -10,324 | -10,324 |
| Common Stock Issued | 165 | 1,023 | 425 | 323 | 149 |
| Other Financing Activity | -5,216 | 1,847 | -75 | 0 | 0 |
| Financing Cash Flow | $-5,311 | $-7,550 | $-9,974 | $-10,001 | $-10,175 |
| Exchange Rate Effect | -164 | -416 | -31 | -47 | 55 |
| Beginning Cash Position | 55,633 | 42,332 | 42,332 | 42,332 | 42,332 |
| End Cash Position | 49,350 | 55,633 | 136,280 | 47,831 | 25,738 |
| Net Cash Flow | $-6,283 | $13,301 | $93,948 | $5,499 | $-16,594 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,996 | 22,199 | 19,467 | 19,616 | -4,395 |
| Capital Expenditure | -2,240 | -4,242 | -2,875 | -1,820 | -556 |
| Free Cash Flow | 756 | 17,957 | 16,592 | 17,796 | -4,951 |